Eli Lilly (NY:LLY)

Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be reporting earnings this Tuesday after market hours. Here’s what you need to know.

Topics Artificial Intelligence

Supernus Pharmaceuticals (SUPN) Reports Q3: Everything You Need To Know Ahead Of Earnings

November 02, 2025

Now is a great time to be shopping for stocks that can anchor your portfolio.

Topics Artificial Intelligence

Rethinking Your Portfolio: The Stocks That Could Outperform for Years ↗

November 02, 2025

Viking's stock surged in one trading session after a positive clinical trial report last year.

Topics Bonds Retirement

Should You Buy Viking Therapeutics Before Nov. 5? ↗

November 02, 2025

Should You Buy the Vanguard S&P 500 ETF With the Stock Market at All-Time Highs? History Offers a Clear Answer ↗

November 02, 2025

Powerful themes like artificial intelligence (AI) continue to drive the S&P 500 to new highs.

The biopharmaceutical industry is undergoing an immediate and profound transformation, as Artificial Intelligence (AI) rapidly compresses timelines, drastically reduces costs, and significantly...

Topics Artificial Intelligence ETFs Economy

AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio

November 01, 2025

Four are already actionable, with the holdout just below a possible breakout.

Topics Animal Testing Artificial Intelligence Economy

S&P 500 Giants JPMorgan, Eli Lilly Lead Five Stocks Near Buy Points ↗

November 01, 2025

Shares of life sciences company Bio-Techne (NASDAQ:TECH) jumped 2.8% in the afternoon session after Baird adjusted its price target on the company, signaling a more positive outlook. The investment...

Topics Stocks

Why Bio-Techne (TECH) Stock Is Up Today

October 31, 2025

Eli Lilly shares rise as Q3 revenue jumps 54% to $17.6 billion, earnings top estimates, and analysts lift price targets on strong obesity drug momentum.

Topics Artificial Intelligence Supply Chain World Trade

Eli Lilly Seen In 'Pole Position' For Growth, Analysts Say ↗

October 31, 2025

Via Benzinga

AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs

October 31, 2025

San Francisco, CA – October 31, 2025 – Artificial intelligence (AI) is ushering in a transformative era for the pharmaceutical industry, particularly in the often-overlooked yet critical domain of...

AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine

Topics Artificial Intelligence Supply Chain

October 31, 2025

Artificial intelligence (AI) is ushering in a transformative era for pharmaceutical research and development (R&D), fundamentally reshaping how new medicines are discovered, developed, and brought to...

The pharmaceutical industry is in the midst of a profound and rapid transformation, driven by the pervasive integration of Artificial Intelligence (AI). What was once a futuristic concept is, by late...

Topics Artificial Intelligence Intellectual Property

AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future

October 31, 2025

Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session after it reported strong third-quarter financial results that surpassed expectations and...

Topics Animal Testing Artificial Intelligence Economy

Why iRhythm (IRTC) Stock Is Trading Up Today

October 31, 2025

Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think) ↗

Topics Artificial Intelligence World Trade

October 31, 2025

Novartis is set to boost its developmental pipeline with this acquisition.

Wall Street slipped on Thursday as disappointing results from Meta and cautious tones from the Fed weighed on sentiment. But after the closing bell, Apple’s record-breaking numbers helped restore a bit...

Meta Meltdown Sends Nasdaq Tumbling as Apple Shines After Hours ↗

October 31, 2025

Via Chartmill

Topics Economy

Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise ↗

October 31, 2025

Traders on Stocktwits linked Novo Nordisk’s renewed bid for Metsera to competition from Viking’s obesity drug VK2735, fueling further optimism.

Via Stocktwits

1 Healthcare Stock with Impressive Fundamentals and 2 We Ignore

October 31, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Twilio stock rose after the software maker reported Q3 earnings that topped estimates and hiked its full-year revenue outlook.

Topics Stocks

Twilio Stock Rises On Q3 Earnings Beat, Raised Guidance ↗

October 30, 2025

Cloudflare stock wavered after the company reported Q3 earnings that topped estimates and guidance came in slightly above views.

Topics Artificial Intelligence Earnings

Cloudflare Earnings Top Estimates. Revenue Outlook Above Views. ↗

October 30, 2025

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗

Topics Artificial Intelligence

October 30, 2025

As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.

Via Benzinga

Topics ETFs

'Our GPUs Are Everywhere’ According to CEO Jensen Huang as Nvidia Doubles Down on AI, Quantum, and 6G

October 30, 2025

Nvidia stock continues to surge higher as the AI chipmaker widens its moat significantly.

Via Barchart.com

Topics Artificial Intelligence

Eli Lilly (LLY) Stock Trades Up, Here Is Why

October 30, 2025

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the morning session after the company reported a "beat and raise" quarter.

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome...

Topics Artificial Intelligence Economy Government

Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗

October 30, 2025

Via Benzinga

Topics Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

October 30, 2025

Via Benzinga

Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera ↗

October 30, 2025

Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.

Nvidia's $5 trillion valuation record is igniting momentum across semiconductor and AI-themed ETFs as investors chase the next leg of the chip supercycle.

Topics Economy Government

Nvidia's $5 Trillion Milestone Turns These AI ETFs Into Hot Trades ↗

October 30, 2025

Via Benzinga

Topics Artificial Intelligence ETFs

Tech Titans Tumble, Alphabet Soars as Market Opens Mixed on AI Spending Jitters

October 30, 2025

The U.S. stock market opened with a palpable sense of divergence on October 30, 2025, as investors grappled with a mixed bag of quarterly earnings and forward-looking statements from the nation's...

Via MarketMinute

Topics Artificial Intelligence Economy Fraud

Eli Lilly (LLY) Q3 2025 Earnings Call Transcript ↗

October 30, 2025

Eli Lilly (LLY) Q3 2025 Earnings Call Transcript